๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
KSX01-TCRT Injection Project in Solid Tumors
NCT05811975TCR-T Cells, Refractory Solid Tumors, Relapsed Solid Tumors
TCRx Therapeutics Co.Ltd
Phase EARLY_PHASE1
50
Nanning
2023-03-07
Active, closed
Study of Low-Dose Radiotherapy Concurrent Chemotherapy With Serplulimab for Patients With ES-SCLC
NCT05765825Extensive-stage Small-cell Lung Cancer
Sichuan University
Phase 2
61
Chongqing, Shantou, Wuhan, Shenyang, Jinan, Shanghai, Chengdu, Guiyang
2023-03-07
Active, closed
A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer
NCT05635708Non-small Cell Lung Cancer, Metastatic Non-small Cell Lung Cancer
BeiGene
Phase 2
400
Hefei, Beijing, Fuzhou, Baoding, Harbin, Zhengzhou, Wuhan, Nantong
2023-03-07
Recruiting
A Study in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) to Evaluate How Safe Long-term Treatment With Pozelimab + Cemdisiran Combination Therapy is and How Well it Works
NCT05744921Paroxysmal Nocturnal Hemoglobinuria
Regeneron Pharmaceuticals
Phase 3
202
2023-03-07
Recruiting
Evaluation of COVID-19 Immune Barrier and Reinfection Risk
NCT05774093COVID-19 Infection, Immunization; Infection
Sun Yat-sen University
Observational
300
Guangzhou
2023-03-06
Recruiting
Biomarker and Imaging Package Study in Immune Effector Cell-Associated Neurotoxicity Syndrome
NCT05643092Immune Effector Cell Associated Neurotoxicity Syndrome
zhang shoulong
Observational
50
Shijiazhuang
2023-03-06
Recruiting
Post-market European & Asian Registry to Evaluate the Minosโ„ข Stent-Graft and Delivery System in Abdominal Aortic Aneurysm Treatment
NCT07674173Endovascular Repair of Infrarenal Abdominal Aortic Aneurysm Using Endovascular Stent Graft
Shanghai MicroPort Endovascular MedTech๏ผˆGroup๏ผ‰Co., Ltd
Observational
200
Lanzhou, Meizhou, Shenzhen, Changsha, Xiangtan, Yueyang, Zibo, Binhai
2023-03-05
Active, closed
Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)
NCT05512910Ischemic Stroke, Acute, Minocycline, Endovascular Treatment, Basilar Artery Occlusion
Xijing Hospital
Phase 4
90
Xi'an
2023-03-04
Active, closed
A Study to Learn About a New Medicine Called Vepdegestrant (ARV-471, PF-07850327) in People Who Have Advanced Metastatic Breast Cancer
NCT05654623Advanced Breast Cancer
Pfizer
Phase 3
624
Hefei, Beijing, Fuzhou Fujian, Foshan, Guangzhou, Nanning, Harbin, Luoyang
2023-03-03
Recruiting
A Phase Ib Clinical Trial of Peguricase for Injection With Methotrexate in Patients With Uncontrolled Gout.
NCT06298071Gout
Shanghai Institute Of Biological Products
Phase 1
36
Bengbu
2023-03-03
Recruiting
HEC73543 Versus Salvage Chemotherapy in R/R FLT3-ITD AML
NCT05586074Leukemia, Acute Myeloid (AML)
Sunshine Lake Pharma Co., Ltd.
Phase 3
324
Hanzhou
2023-03-03
Recruiting
Chidamide in Combination With Azacitidine, Liposomal Mitoxantrone, and Prednisone (CAMP Regimen) for the Treatment of Previously Untreated Nodal TFH Cell Lymphoma
NCT05958719Peripheral T Cell Lymphoma, Epigenetic Repression
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
37
Tianjin
2023-03-02
Active, closed
Energy Metabolism Profiles Over Weight-loss and Eating Responses
NCT05785221Homeostasis, Metabolism and Nutrition Disorder, Healthy, Obesity
Chinese Academy of Sciences
Not applicable
117
Hangzhou
2023-03-02
Recruiting
A Phase I Clinical Study of Recombinant Humanized Anti-CD20(B-lymphocyte Antigen CD20) Monoclonal Antibody Subcutaneous Injection in the Treatment of Primary Membranous Nephropathy
NCT05668403Primary Membranous Nephropathy
Shanghai Jiaolian Drug Research and Development Co., Ltd
Phase 1
52
Zhengzhou, Shijiazhuang, Hangzhou, Beijing, Shanghai
2023-03-02
Recruiting
Pre-warning Risk Scoring System for Sudden Cardiac Death
NCT06440083Sudden Cardiac Death
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
100,000
Guanzhou
2023-03-02
Recruiting
A Study of AK129 in Patients With Advanced Malignant Tumors
NCT05645276Advanced Malignant Tumors(Stage IA-IB)
Akeso
Phase 1
182
Beijing
2023-03-02
Active, closed
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1)
NCT05639114Systemic Lupus Erythematosus
Novartis Pharmaceuticals
Phase 3
436
Guangzhou, Shantou, Haikou, Zhuzhou, Nanjing, Suzhou, Nanchang, Pingxiang
2023-03-02
Recruiting
A Phase I Study of HS-10386 in Participants With Advanced Solid Tumors
NCT05911464Advanced Solid Tumor
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Phase 1
248
Shanghai
2023-03-02
Recruiting
Camrelizumab in Combination With Apatinib Mesylate Plus Short-course Chemotherapy for Advanced ESCC
NCT05738434Esophageal Cancer by AJCC V8 Stage
The First Affiliated Hospital of Zhengzhou University
Phase 2
188
Zhengzhou
2023-03-02
Not yet open
Study of Telitacicept in Patients With Refractory IgA Nephropathy
NCT05596708IgA Nephropathy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2/3
40
Hangzhou
2023-03-01
Active, closed
Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immunotherapy
NCT05585580Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Qilu Hospital of Shandong University
Phase 2
59
Jinan, Qingdao, Yantai, Linyi
2023-03-01
Recruiting
Longitudinal Data Registry of Plasma Cell Dyscrasia
NCT06760052Multiple Myeloma and Other Plasma Cell Neoplasms
Shanghai Zhongshan Hospital
Observational
2,000
Shanghai
2023-03-01
Recruiting
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
NCT05593458Locally Advanced Gastric Carcinoma
Zhejiang University
Phase 3
190
Hangzhou
2023-03-01
Recruiting
AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors
NCT06286267Phyllodes Breast Tumor, Artificial Intelligence, Multiomics, Prognostic Cancer Model
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
4,000
Guangzhou
2023-03-01
Recruiting
Long-term Efficacy and Safety Evaluation of Growth Hormone in Children in China(CGLS)
NCT06110910Childhood Short Stature
Xiaoping Luo
Observational
10,000
Wuhan
2023-03-01
Recruiting
Enucleation of Pancreatic Tumor by Blocking Abdominal Trunk and Superior Mesenteric Artery
NCT06164769Tumor of Pancreas, Surgical Blood Loss
Zhejiang University
Not applicable
30
Hangzhou
2023-03-01
Recruiting
Surgical-imaging Research on Obesity (SIRO)
NCT06268262Overweight and Obesity
The Affiliated Hospital of Xuzhou Medical University
Observational
200
Xuzhou
2023-03-01
Recruiting
A Clinical Study of Fundus OCTA for the Identification of CMD
NCT05743140Coronary Microvascular Disease
Peking University First Hospital
Observational
400
Beijing
2023-03-01
By invitation
FMT in Transplant-related Gastrointestinal Mucositis
NCT07622849Transplant-related Gastrointestinal Mucositis
The First Affiliated Hospital of Soochow University
Observational
20
Suzhou
2023-03-01
Recruiting
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
NCT07265544Liver Neoplasm, HBV Infection, Non-alcoholic Fatty Liver Disease NAFLD, Liver Fibrosis
Nanfang Hospital, Southern Medical University
Observational
240
Guangzhou
2023-03-01
Not yet open
Adjuvant Stereotactic Body Radiotherapy (SBRT) for Hepatocellular Carcinoma After Hepatectomy With Narrow Margin: a Prospective, Multi-center, Randomized Controlled, Open-labelled, Phase III Study
NCT05602974Hepatocellular Carcinoma, Narrow Margin, Adjuvant Stereotactic Body Radiotherapy, Hepatectomy
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
140
Hangzhou
2023-03-01
Recruiting
Combined Screening for Gastrointestinal Tumors
NCT06478030Gastrointestinal Tumors
Zhejiang Cancer Hospital
Observational
200,000
Jinhua, Ningbo
2023-03-01
Recruiting
Association of Gestational Cardiovascular Health With Pregnancy Outcomes
NCT05776082Pregnant Women
Women's Hospital School Of Medicine Zhejiang University
Observational
5,000
Hangzhou, Taizhou
2023-03-01
Recruiting
Prospective Collection of Therapeutic Efficacy and Safety Data in Patients with Unresectable Hepatocellular Carcinoma
NCT06788353Transarterial Chemoembolization, Systemic Therapy, Unresectable Hepatocellular Carcinoma
Sun Yat-sen University
Observational
500
Guangzhou
2023-03-01
Recruiting
AI-Driven Prediction of Biological Age With EHR
NCT06791486Biological Age
The Eye Hospital of Wenzhou Medical University
Observational
1,000,000
Guangzhou, Wenzhou
2023-03-01
Recruiting
Exploring the Predictive Value of Electroencephalography Features in Perioperative Neurocognitive Disorders Following Cardiovascular Surgery
NCT06692309Cardiovascular Surgery, Perioperative Neurocognitive Disorders
Beijing Chao Yang Hospital
Observational
100
Beijing
2023-03-01
Recruiting
Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
NCT05768503Metastatic Microsatellite-stable Colorectal Cancer
Sun Yat-sen University
Phase 3
176
Hefei, Foshan, Guangzhou, Nanning, Harbin, Zhengzhou, Nanchang, Shanghai
2023-03-01
Recruiting
Tirelizumab in Combination With Carboplatin and Albumin-binding Paclitaxel for Neoadjuvant Therapy in HNSCC
NCT05941338Head and Neck Squamous Cell Carcinoma, Oral Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 2
100
Guangzhou
2023-03-01
Recruiting
Study of Individualized, Precise and Standardized Cervical Open-door Surgery for Cervical Spinal Stenosis
NCT05786313Cervical Spinal Stenosis, Cervical Spinal Cord Injury, Individuation, Standardization
Xijing Hospital
Not applicable
500
Xi'an
2023-03-01
Recruiting
Nimotuzumab Concurrent With Chemoradiotherapy for Patients With Unresectable Esophageal Squamous Cell Carcinoma
NCT06410651Esophageal Cancer, Nimotuzumab, Chemoradiotherapy, Chemotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
53
Beijing
2023-03-01
Recruiting
Study On the Expression Level and Clinical Significance of VISTA in Patients With Vascular Cognitive Impairment
NCT06342661Cerebrovascular Disease Small Vessel
First Affiliated Hospital of Harbin Medical University
Observational
400
Harbin
2023-03-01
Active, closed
Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer
NCT05759572Breast Cancer Metastatic
Fudan University
Phase 2
145
Shanghai
2023-03-01
Recruiting
Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)
NCT05870969Carcinoma, Hepatocellular, Hepatitis C, Chronic, Hepatitis B, Chronic, Cirrhosis, Liver
Ruijin Hospital
Observational
20,000
Shanghai
2023-03-01
Recruiting
First in Human Study of EMB-07 in Locally Advanced/Metastatic Solid Tumors or Relapse/Refractory Lymphoma
NCT05607498Advanced/Metastatic Solid Tumors, Relapse/Refractory Lymphoma
EpimAb Biotherapeutics (Suzhou)Co., Ltd.
Phase 1
150
Changsha, Baoding, Beijing, Bengbu, Guangzhou, Harbin, Shandong, Tianjin
2023-03-01
Recruiting
Neoadjuvant WX-0593 in Resectable ALK-positive or ROS1-positive Non-small Cell Lung Cancer
NCT05765877Non-Small Cell Lung Cancer(NSCLC)
Pingping Song
Phase 2
26
Jinan
2023-03-01
Recruiting
Venetoclax Combined With Homoharringtonine and Cytarabine in Induction for AML
NCT05805098Acute Myeloid Leukemia
The First Affiliated Hospital of Soochow University
Phase 2/3
60
Suzhou
2023-03-01
Recruiting
Comparison of an Acceleromyography- and Electromyography-based Neuromuscular Monitor With TOF-Watch ยฎ Monitor
NCT05632107Neuromuscular Blockade
Huazhong University of Science and Technology
Observational
100
Wuhan
2023-03-01
Active, closed
Aqueous Humor Proteome in Retinal Vein Occlusion With Macular Edema
NCT07106268Retinal Vein Occlusion
Tianjin Medical University Eye Hospital
Observational
100
Tianjin
2023-03-01
Active, closed
An Organoid-on-chips Technique Based on Biopsy Samples and Its Efficacy in Predicting the Response to HAI in HCC
NCT05932836Hepatocellular Carcinoma
Xiangya Hospital of Central South University
Observational
165
Changsha
2023-03-01
Recruiting
Construction of Molecular Diagnostic Marker Model for Pancreatic Cystic Tumors Based on Pancreatic Cystic Fluid Samples
NCT05737953Pancreatic Neoplasms, DNA Methylation, Proteome
Zhaoshen Li
Observational
100
Shanghai
2023-03-01
Active, closed
Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology
NCT06865898HBV Related Acute-on-chronic Liver Failure
Qilu Hospital of Shandong University
Observational
58
Jinan
2023-03-01
Recruiting
An Exploratory Clinical Trial of VGN-R08b in Patients With Type II Gaucher Disease
NCT06272149Type II Gaucher Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
6
Shanghai
2023-03-01
Recruiting
Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer Patients
NCT05771181Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma
Fudan University
Phase 2
25
Shanghai
2023-03-01
Recruiting
CART-PSMA Cells for Advanced Prostate Cancer
NCT05656573Prostate Cancer
Nova Therapeutics LLC
Phase 1
20
Beijing
2023-03-01
Recruiting
Efficacy and Safety of Apantamide Combined With Docetaxel and ADT vs. Apantamide Combined With ADT in Patients With High Tumor Burden mHSPC: a Multicenter and Prospective Cohort Study
NCT05713578Cohort Studies
Qilu Hospital of Shandong University
Phase EARLY_PHASE1
220
Jinan
2023-03-01
Recruiting
Nimotuzumab Concurrent With Chemoradiotherapy for Esophageal Cancer Patients
NCT06429839Esophageal Cancer, Nimotuzumab, Chemoradiotherapy, Chemotherapy
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
55
Beijing
2023-03-01
Not yet open
SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)
NCT05718232Advanced Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3
136
Guangzhou
2023-03
Recruiting
Rezvilutamide in Patients With Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
NCT05753566Prostate Cancer, Biochemical Recurrence
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2
96
Nanjing
2023-03
Recruiting
Serplulimab Combined With FOLFIRI and Bevacizumab in the Treatment of Colon Cancer Peritoneal Metastases
NCT05742425Unresectable Colon Cancer Peritoneal Metastases, PMMR/Ras/BRAF Wild-type
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
30
Huzhou
2023-03
Recruiting
Zoledronic Acid-loaded Bone Cement as a Local Adjuvant Therapy for Giant Cell Bone Tumor After Intralesional Curettage
NCT05595603Giant Cell Tumor of Bone
Second Affiliated Hospital, Zhejiang University, School of Medicine
Phase 2
153
Hangzhou
2023-03
Not yet open
CAPEOX vs Observation in Colorectal Cancer Patients With Positive MRD
NCT05699746Colorectal Cancer
Zhejiang University
Phase 3
38
Shanghai, Hangzhou, Ningbo
2023-03
Not yet open
Imapct of bioMarkers on Pharmacodynamics and Bleeding Risk of Direct Oral AntiCoagulants and Ticagrelor Study II
NCT05764356Novel Oral Anticoagulants, NOACs, Rivaroxaban, Apixaban
Peking University First Hospital
Observational
2,000
Hefei, Beijing, Chongqing, Zhengzhou, Shanghai
2023-03
Not yet open
SBRT Combined With Fruquintinib Plus PD-1/CTLA-4 Antibody for Third-line Treatment in mCRC
NCT05747716Metastatic Colorectal Cancer
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2
44
Wuhan
2023-02-28
Active, closed
Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.
NCT05201066Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic
Novartis Pharmaceuticals
Phase 2
33
Changchun, Tianjin
2023-02-28
Recruiting
Development and Validation of a Real-time Prediction Model for Acute Kidney Injury in Hospitalized Patients
NCT06597838Prediction Model
Peking University First Hospital
Observational
161,876
Beijing
2023-02-28
Recruiting
The Efficacy of Vosevi in Treating DAA-experienced Patients
NCT06180590Chronic Hepatitis C, Medication Reaction
The Third Affiliated Hospital of Guangzhou Medical University
Observational
200
Guangzhou
2023-02-28
Recruiting
Exploring the Predicting Biomarkers From Mild Cognitive Impairment to Dementia (EBMID)
NCT05697588Biomarkers, MCI Conversion to Dementia
Cuibai Wei๏ผŒClinical Professor
Observational
900
Beijing
2023-02-28
Recruiting
APG-115 Alone or in Combination With APG-2575 in Recurrent or Refractory Neuroblastoma or Solid Tumors
NCT05701306Neuroblastoma, Solid Tumor
Ascentage Pharma Group Inc.
Phase 1/2
100
Guangzhou, Wuhan, Tianjin
2023-02-28
Active, closed
A Study of HX008 Compared to Chemotherapy in the First-Line Treatment of Subjects With MSI-H/dMMR Metastatic Colorectal Cancer
NCT05652894Metastatic Colorectal Cancer
Taizhou Hanzhong biomedical co. LTD
Phase 3
190
Bengbu, Fuyang, Hefei, Beijing, Fuzhou, Lanzhou, Foshan, Guangzhou
2023-02-28
Recruiting
Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic Tumors
NCT05847855Pancreatic Neuroendocrine Tumor, Solid Pancreatic Neoplasms
Fudan University
Observational
1,000
Shanghai, Chengdu
2023-02-27
Active, closed
LX102 in Patients With Neovascular Age-Related Macular Degeneration (nAMD)
NCT06198413Neovascular Age-Related Macular Degeneration
Innostellar Biotherapeutics Co.,Ltd
Phase 1
12
Hefei, Hangzhou, Shanghai
2023-02-27
Not yet open
Evaluating the Effect of the Automatic Surveillance System on Surveillance Rate of Colorectal Postpolypectomy Patients
NCT05751824Artificial Intelligence, Surveillance
Renmin Hospital of Wuhan University
Not applicable
867
Jiangmen, Wuhan
2023-02-26
Recruiting
Evaluation of Safety and Efficacy of Gene Therapy Drug in the Treatment of Spinal Muscular Atrophy (SMA) Type 1 Patients
NCT05824169Spinal Muscular Atrophy
GeneCradle Inc
Phase 1/2
18
Beijing, Shenyang, Suzhou
2023-02-25
Recruiting
Domestic Violence Enhanced Perinatal Care Program in China
NCT05388565Intimate Partner Violence
University of Texas at Austin
Not applicable
100
Jinan
2023-02-25
Active, closed
AR Training in Adults With Unilateral Amblyopia
NCT06704737Amblyopia Unilateral, Amblyopia Functional
Eye & ENT Hospital of Fudan University
Not applicable
48
Shanghai
2023-02-25
Recruiting
Neurofeedback-Based Digital Therapeutics for the Diagnosis and Treatment of ADHD in Children.
NCT06369714Attention Deficit Disorder With Hyperactivity, Executive Function Disorder
Lei Lei, MD
Not applicable
210
Shanghai
2023-02-24
Active, closed
A Study of ES014 in Patients With Locally Advanced or Metastatic Solid Tumours
NCT05717348Solid Tumor, Locally Advanced Solid Tumor, Metastatic Solid Tumor
Elpiscience (Suzhou) Biopharma, Ltd.
Phase 1
120
Shanghai
2023-02-24
Recruiting
Safety, Tolerability, Pharmacokinetic Characteristics, and Efficacy of CM369 in Advanced Solid Tumors & Hematologic Malignancies
NCT05690581Advanced Solid Tumors and Hematologic Malignancies
Beijing InnoCare Pharma Tech Co., Ltd.
Phase 1
146
Guangzhou, Changchun, Chengdu
2023-02-23
Recruiting
IFNฮฑ Expressing Mesenchymal Stromal Cells for Locally Advanced/Metastatic Solid Tumors
NCT05699811Locally Advanced or Metastatic Solid Tumors
Chinese PLA General Hospital
Phase 1/2
40
Beijing
2023-02-23
Recruiting
Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
NCT06254560Severe Aplastic Anemia, Platelet Transfusion Refractoriness
Institute of Hematology & Blood Diseases Hospital, China
Phase 2
20
Tianjin
2023-02-23
Recruiting
Shared Decision Making in Patients With Lung Cancer
NCT05191485Surgery, Lung Adenocarcinoma
Sichuan Cancer Hospital and Research Institute
Observational
190
Chengdu
2023-02-22
Recruiting
A Study of KC1036 in Patients with Advanced Thymic Tumors
NCT05683886Thymic Tumors
Beijing Konruns Pharmaceutical Co., Ltd.
Phase 2
30
Shanghai, Chengdu
2023-02-22
Recruiting
Serplulimab Combined With CAPEOX + Celecoxib as Neoadjuvant Treatment for Locally Advanced Rectal Cancer
NCT05731726pMMR, MSS, MSI-L, Locally Advanced Rectal Carcinoma
Zhejiang University
Phase 2
50
Hangzhou
2023-02-22
Recruiting
A Study Evaluating the Safety and Efficacy of LentiRed Drug Product in Transfusion-dependent ฮฒ-Thalassemia [TDT]
NCT05762510Transfusion Dependent Beta-Thalassemia
First Affiliated Hospital of Guangxi Medical University
Phase EARLY_PHASE1
5
Nanning
2023-02-22
Recruiting
Fenofibrate Combined With Ursodeoxycholic Acid in Subjects With Primary Biliary Cholangitis
NCT05751967Primary Biliary Cholangitis
Xijing Hospital of Digestive Diseases
Phase 3
150
Lanzhou, Guangzhou, Nanjing, Shenyang, Xi'an, Chengdu, Tianjin
2023-02-22
Recruiting
A Study of C-CAR039 (Prizloncabtagene Autoleucel) in Patients With Relapsed/Refractory Large B-Cell Lymphoma
NCT05800977Relapsed/Refractory Large B-Cell Lymphoma
Shanghai AbelZeta Ltd.
Phase 1/2
112
Beijing, Chongqing, Guangzhou, Hangzhou, Jinan, Nanchang, Nanjing, Shanghai
2023-02-22
Recruiting
Minimally Residual of Esophageal Cancer 001
NCT05952661Esophageal Carcinoma, Minimal Residual Disease
Hebei Medical University Fourth Hospital
Observational
56
Shijiazhuang
2023-02-22
Active, closed
ASKB589 in Combination With CAPOX and PD-1 Inhibitors in Patients With Advanced, and Unresectable G/GEJ Cancer.
NCT05632939Gastric Cancer, Gastroesophageal Cancer (GC)
AskGene Pharma, Inc.
Phase 1/2
62
Beijing
2023-02-21
Active, closed
A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma
NCT05716087Mantle Cell Lymphoma (MCL)
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 2
62
Hefei, Beijing, Chongqing, Fuzhou, Xiamen, Lanzhou, Guangzhou, Meizhou
2023-02-21
Active, closed
A Study of GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
NCT05627856NK/T Cell Lymphoma, Vascular Immunomother T Cell Lymphoma, Non-Hodgkin Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd.
Phase 1/2
4
Guangzhou
2023-02-21
Recruiting
A Study of Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naรฏve Participants With Acute Myeloid Leukemia
NCT05736965AML, Adult
Shanghai Tong Ren Hospital
Phase 2
58
Changzhou, Chengdu, Chโ€™ang-chโ€™un, Haโ€™erbin, Hefei, Jiaxing, Lanzhou, Ningbo
2023-02-20
Recruiting
Observational Cohort Study of Chronic Viral Infection in the Central Nervous System
NCT07512518Progressive Multifocal Leukoencephalopathy, Immune Checkpoint Inhibitors
Peking Union Medical College Hospital
Observational
66
Beijing
2023-02-20
Recruiting
ACOART AVF RENEW: A Post Market Clinical Study
NCT06205576Stenosis of Native Hemodialysis Arteriovenous Fistulas
Acotec Scientific Co., Ltd
Not applicable
164
Beijing
2023-02-20
Recruiting
Beijing Disability Risk and Ageing Monitoring Study
NCT06394817Age Problem, Disability, Death
Xuanwu Hospital, Beijing
Observational
2,000
Beijing
2023-02-20
Active, closed
Safety and Efficacy of ZVS101e in Patients With Bietti 's Crystalline Dystrophy
NCT05832684Bietti's Crystalline Dystrophy
Chigenovo Co., Ltd
Phase 1/2
24
Beijing, Chengdu, Tianjin
2023-02-20
Recruiting
ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
NCT05815082Colorectal Cancer, Liver Metastases, Circulating Tumor Cell, Chemotherapy Effect
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
490
Guangzhou
2023-02-20
Recruiting
Effect of Esmolol on Oxygenation Index in Patients With Acute Respiratory Distress Syndrome
NCT06013319Acute Respiratory Distress Syndrome
Zhiming Jiang
Phase 3
178
Jinan
2023-02-20
Recruiting
Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
NCT05797077Colorectal Cancer, Liver Metastases, Circulating Tumor Cell, Cancer, Therapy-Related
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3
346
Guangzhou
2023-02-20
Recruiting
Sequenced Treatment Alternatives to Relieve Adolescent Depression (STAR-AD)
NCT05814640Depression, Sequestra
First Affiliated Hospital of Chongqing Medical University
Phase 1/2
520
Chongqing
2023-02-20
Recruiting
The Proactive Ophthalmic Examination Cohort
NCT05851287Vision Impairment, Eye Diseases
Zhongshan Ophthalmic Center, Sun Yat-sen University
Observational
5,000
Guangzhou
2023-02-20
Rows per page Showing 15601–15700 of 19052
Previous 155 156 157 158 159 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-china?page=157

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.